The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation

Blood

Volumn 87, Issue 2, 1996, Pages 818-826

  Van Tol, M J D ^a   Gerritsen, E J A ^b   De Lange, G G ^b   Van Leeuwen, A M ^b   Jol Van Der Zijde, C M ^b   Oudeman Gruber, N J ^b   De Vries, E ^b   Radl, J ^b   Vossen, J M ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 0030051860     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.2.818.bloodjournal872818     Document Type: Article

References (39)

1. de Lange GG: Polymorphisms of human immunoglobulins: Gm, Am, Em and Km allotypes. Exp Clin Immunogenet 6:7, 1989
2. Witherspoon RP, Schanfield MS, Storb R, Thomas ED, Giblett ER: Immunoglobulin production of donor origin after marrow transplantation for acute leukemia or aplastic anemia. Transplantation 26:407, 1978
3. Korver K, de Lange GG, Langlois van den Bergh R, Schellekens PTA, van Loghem E, van Leeuwen F, Vossen JM: Lymphoid chimerism after allogeneic bone marrow transplantation: Y-chromatin staining of peripheral T and B lymphocytes and allotyping of serum immunoglobulins. Transplantation 44:643, 1987
4. Yam PY, Petz LD, Knowlton RG, Wallace RB, Stock AD, de Lange GG, Brown VA, Donis-Keller H, Blume KG: Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation 43:399, 1987
5. Petz LD, Yam P, Wallace RB, Stock AD, de Lange G, Knowlton RG, Brown VA, Donis-Keller H, Hill LR, Forman SJ, Blume KG: Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood 70:1331, 1987
6. Schouten HC, Sizoo W, van't Veer MB, Hagenbeek A, Löwenberg B: Incomplete chimerism in erythroid, myeloid and B lymphocyte lineage after T-cell depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 3:407, 1988
7. Schanfield MS, van Loghem E: Human immunoglobulin allotypes, in Weir DM (ed): Handbook of Experimental Immunology, vol 3. Oxford, UK, Blackwell, 1986, p 94.1
8. Mitus AJ, Stein R, Rappeport JM, Antin JH, Weinstein HJ, Alper CA, Smith BR: Monoclonal and oligoclonal gammopathy after bone marrow transplantation. Blood 74:2764, 1989
9. Fischer AM, Simon F, le Deist F, Blanche S, Griscelli C, Fischer A: Prospective study of the occurrence of monoclonal gammapathies following bone marrow transplantation in young children. Transplantation 49:731, 1990
10. Gerritsen EJA, van Tol MJD, Lankester AC, van der Weijden-Ragas CPM, Jolvan der Zijde CM, Oudeman-Gruber NJ, Radl J, Vossen JM: Immunoglobulin levels and monoclonal gammopathies in children after bone marrow transplantation. Blood 82:3493, 1993
11. Nezelof C: Thymic dysplasia with normal immunoglobulins and immunologic deficiency Pure alymphocytosis, in Bergsma D, Good RA (eds): Immunologic Deficiency Diseases in Man. Birth Defects, Original Article Series, vol 4. New York, NY, Liss, 1968, p 104
12. Storb R, Thomas ED, Weiden PL, Buckner CD, Clift RA, Fefer A, Fernando LP, Giblett ER, Goodell BW, Johnson FL, Lerner KG, Neiman PE, Sanders JE: Aplastic anemia treated by allogeneic bone marrow transplantation: A report on 49 new cases from Seattle. Blood 48:817, 1976
13. Vossen JM, Heidt PJ, van den Berg H, Gerritsen EJA, Hermans J, Dooren LJ: Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur J Clin Microbiol Infect Dis 9:14, 1990
14. Jol-van der Zijde CM, Labadie J, Vlug A, Radl J, Vossen JM, van Tol MJD: Dot-immunobinding assay as an accurate and versatile technique for the quantification of human IgG subclasses. J Immunol Methods 108:195, 1988
15. de Lange GG, van Leeuwen AM, Vlug A, van Eede PH, Engelfriet CP, Lincoln PJ. Monoclonal antibodies against IgG allotypes G1m(z), G1m(a), G1m(f), G3m(b1/u) and G3m(g1): Their usefulness in HAI and capture ELISA. Exp Clin Immunogenet 6:18, 1989
16. Jefferis R, Reimer CB, Skvaril F, de Lange G, Ling NR, Lowe J, Walker MR, Phillips DJ, Aloisio CH, Wells TW, Vaerman JP, Magnusson CG, Kubagawa H, Cooper M, Vartdal F, Vandvik B, Haaijman JJ, Makela O, Sarnesto A, Lando Z, Gergely J, Rajnavölgyi E, László G, Radl J, Molinaro GA: Evaluation of monoclonal antibodies having specificity for human IgG sub classes: Results of an IUIS/WHO collaborative study Immunol Lett 10:223, 1985
17. Jefferis R, Reimer CB, Skvaril F, de Lange GG, Goodall DM, Bentley TL, Phillips DJ, Vlug A, Harada S, Radl J, Claassen E, Boersma JA, Coolen J: Evaluation of monoclonal antibodies having specificity for human IgG subclasses: Results of the 2nd IUIS/WHO collaborative study. Immunol Lett 31:143, 1992
18. Wieme RJ: An improved technique of agar-gel electrophoresis on microscope slides. Clin Chim Acta 4:317, 1959
19. Nooij FJM, van der Sluijs-Gelling AJ, Jol-van der Zijde CM, van Tol MJD, Haas H, Radl J: Immunoblotting techniques for the detection of low level homogeneous immunoglobulin components in serum. J Immunol Methods 134:273, 1990
20. Rautonen N, Sarvas H, Mäkelä O: One allele [G2m(n)] of the human IgG2 locus is more productive than the other. Eur J Immunol 19:817, 1989
21. l in homozygotes and heterozygotes. J Immunol 151:2529, 1993
22. van Leeuwen JEM, van Tol MJD, Bodzinga BG, Wijnen JT, van der Keur M, Joosten AM, Tanke HJ, Vossen JM, Meera Khan P: Detection of mixed chimaerism in flow sorted cell subpopulations by PCR-amplified VNTR markers after allogeneic bone marrow transplantation. Br J Haematol 79:218, 1991
23. van den Berg H, Vossen JM, Langlois van den Bergh R, Bayer J, van Tol MJD: Detection of Y chromosome by in situ hybridization in combination with membrane antigens by two-color immunofluorescence. Lab Invest 64:623, 1991
24. Sparkes RS, Sparkes MC, Gale RP: Immunoglobulin synthesis following allogeneic bone marrow transplantation in man: Conversion to donor allotype. Transplantation 27:212, 1979
25. Labadie J, van Tol MJD, Dijkstra NH, van der Kaaden M, Jol-van der Zijde CM, de Lange GG, Zwaan FE, Vossen JM: Transfer of specific immunity from donor to recipient of an allogeneic bone marrow graft: Evidence for donor origin of the antibody producing cells. Br J Haematol 82:437, 1992
26. Flesland O, Solheim BG, Mellbye OJ, Vandvik B, Albrechtsen DA: Quantitation of immunoglobulins produced by donor lymphocytes in transplant patients and the possible identification of donor cell-produced antiviral antibodies by imprint immunofixation. Scand J Immunol 32:149, 1990
27. van Tol MJD, Gerritsen EJA, Lankester AC, Jol-van der Zijde CM, de Lange GG, van Leeuwen AM, Radl J, Vossen JM: Allotypes of homogeneous immunoglobulins after allogeneic bone marrow transplantation, in Radl J, van Camp B (eds): Monoclonal Gammapathies II: Clinical Significance and Basic Mechanisms. Topics in Aging Research in Europe, vol 12. Rijswijk, The Netherlands, EURAGE, 1989, p 203
28. Hibi T, Dosch H-M: Lymphocyte function in human bone marrow. III. Isotype commitment, metabolic and secretory characteristics of immunoglobulin producing cells. Cell Immunol 98:34, 1986
29. Hibi T, Chan MA, Petsche D, Dosch H-M: Phenotype, frequency, and EBV responsiveness of human marrow B and pre-B cells. J Immunol 136:3211, 1986
30. van Leeuwen JEM, van Tol MJD, Joosten AM, Wijnen JT, Venveij PJM, Meera Khan P, Vossen JM: Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse. Blood 83-3059, 1994
31. Hill RS, Petersen FB, Storb R, Appelbaum FR, Doney K, Dahlberg S, Ramberg R, Thomas ED: Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft versus host disease. Blood 67:811, 1986
32. Gahrton G, Tura S, Ljungman P, Belanger C, Brandt L, Cavo M, Facon T, Granena A, Gore M, Gratwohl A. Löwenberg B, Nikoskelainen J, Reiffers JJ, Samson D, Verdonck L, Volin L: Allogeneic bone marrow transplantation in multiple myeloma. N Engl J Med 325:1267, 1991
33. Bensinger WI, Buckner CD, Clift RA, Petersen FB, Bianco JA, Singer JW, Appelbaum FR, Dalton W, Beatty P, Fefer A, Storb R, Thomas ED, Hansen JA: Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma. J Clin Oncol 10:1492, 1992
34. Cavo M, Tura S, Rosti G, Grimaldi M, Bandini G, Bonelli MA, Calori E, Rizzi S, van Lint MT, Bacigalupo A, Marmont A, Aversa F, Martelli M, Polchi P, Lucarelli G: Allogeneic BMT for multiple myeloma (MM). The Italian experience. Bone Marrow Transplant 7:31, 1991 (suppl 2)
35. Reece DE, Shepherd JD, Klingemann HG, Sutherland HJ, Nantel SH, Barnett MJ, Spinelli J, Phillips GL: Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantation. Bone Marrow Transplant 15:117, 1995
36. Kapoor N, Avalos BR, Copelan EA, Cunningham P, Klein J, Keever C, Tutschka PJ: Bone marrow transplantation for multiple myeloma with busulfan and cyclophosphamide conditioning regimen: Slow disappearance of plasma cells from bone marrow following transplantation. Exp Hematol 19:574, 1991 (abstr)
37. Barlogie B, Epstein J, Selvanayagam P, Alexanian R: Plasma cell myeloma - New biological insights and advances in therapy. Blood 73:865, 1989
38. Radl J: Monoclonal gammapathies in immunodeficient adults, in Radl J, van Camp B (eds): Monoclonal Gammapathies II: Clinical Significance and Basic Mechanisms. Topics in Aging Research in Europe, vol 12. Rijswijk, The Netherlands. EURAGE, 1989, p 45
39. Bird JM, Russell NH, Samson D: Minimal residual disease after bone marrow transplantation for multiple myeloma: Evidence for cure in long-term survivors. Bone Marrow Transplant 12:651, 1993